Not too far away now. I would say a few more months should see a positive announcement and more before end of calendar year.
I am confident our dossiers are quality and goid for approval. As I have said before, the FDA is super slow. Everybody has to deal with that.
Ann: Acrux's fourth generic dossier accepted by FDA for review, page-37
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
